Your browser doesn't support javascript.
loading
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles.
Gustà, Muriel F; Edel, Michael J; Salazar, Vivian A; Alvarez-Palomo, Belén; Juan, Manel; Broggini, Massimo; Damia, Giovanna; Bigini, Paolo; Corbelli, Alessandro; Fiordaliso, Fabio; Barbul, Alexander; Korenstein, Rafi; Bastús, Neus G; Puntes, Víctor.
Afiliação
  • Gustà MF; Institut Català de Nanociència i Nanotecnologia (ICN2), Consejo Superior de Investigaciones Científicas (CSIC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Edel MJ; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
  • Salazar VA; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
  • Alvarez-Palomo B; Hospital Clínic de Barcelona, Servei Immunologia-IDIBAPS, Barcelona, Spain.
  • Juan M; Unit of Anatomy and Embryology, Universitat Autònoma de Barcelona, Faculty of Medicine, Barcelona, Spain.
  • Broggini M; University of Western Australia, Faculty of Medicine, Discipline of Medical Sciences and Genetics, School of Biomedical Sciences, Perth, WA, Australia.
  • Damia G; Institut Català de Nanociència i Nanotecnologia (ICN2), Consejo Superior de Investigaciones Científicas (CSIC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Bigini P; Banc de Sang i Teixits, Cell Therapy Service, Barcelona, Spain.
  • Corbelli A; Hospital Clínic de Barcelona, Servei Immunologia-IDIBAPS, Barcelona, Spain.
  • Fiordaliso F; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
  • Barbul A; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
  • Korenstein R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
  • Bastús NG; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
  • Puntes V; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Front Immunol ; 14: 1128582, 2023.
Article em En | MEDLINE | ID: mdl-37228592
ABSTRACT

Introduction:

Gene therapy holds promise to cure various diseases at the fundamental level. For that, efficient carriers are needed for successful gene delivery. Synthetic 'non-viral' vectors, as cationic polymers, are quickly gaining popularity as efficient vectors for transmitting genes. However, they suffer from high toxicity associated with the permeation and poration of the cell membrane. This toxic aspect can be eliminated by nanoconjugation. Still, results suggest that optimising the oligonucleotide complexation, ultimately determined by the size and charge of the nanovector, is not the only barrier to efficient gene delivery.

Methods:

We herein develop a comprehensive nanovector catalogue comprising different sizes of Au NPs functionalized with two different cationic molecules and further loaded with mRNA for its delivery inside the cell. Results and

Discussion:

Tested nanovectors showed safe and sustained transfection efficiencies over 7 days, where 50 nm Au NPs displayed the highest transfection rates. Remarkably, protein expression was increased when nanovector transfection was performed combined with chloroquine. Cytotoxicity and risk assessment demonstrated that nanovectors are safe, ascribed to lesser cellular damage due to their internalization and delivery via endocytosis. Obtained results may pave the way to design advanced and efficient gene therapies for safely transferring oligonucleotides.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article